Claris Lifescience has received major setback during the third quarter ended December 2015 and it incurred a standalone net loss of Rs. 68.87 crore as against a net profit of Rs. 89.85 crore in the corresponding period of last year. The company's ... PharmaBiz, 4 days ago
Claris crashes 7% post poor Q3 performance - India Infoline, 4 days ago
Claris Lifesciences reports consolidated net loss of Rs 68.87 crore in the December 2015 quarter - Business Standard, 6 days ago
3 images for "claris lifesciences"
DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"Business Standard, 1 week ago Claris Lifesciences informs about company updates Finalaya.com, 1 month ago Claris Lifesciences provides business update Capital Market, 1 month ago
*Password should have 8 to 12 Alphanumeric Characters with one Special Character. Confirm Password I want to create a User ID and have read the terms and conditions for the same Register Now Connect with We encourage visitors to register on IIFL. Registering ...India Infoline, 4 days ago
It has been a tumultuous week for the Indian stock market. Memories of Jan 2008 and Jan 2011 have returned to haunt the market as the sharp crash in the indices sent Nifty below 7000 levels this week. Recent crash can be attributed to global rout, ...India Infoline, 6 hours ago
About one out of five stocks from the BSE500 index are now trading more than 50% discounts to their 52-week highs, following an over 10% fall in the benchmark BSE Sensex over the past one-and-half months. A total of 83 stocks from the BSE-500 are ...Smart Investor, 9 hours ago
Private equity firm Carlyle Group LP has raised over $3 billion in commitments for a new long-term PE fund that will have a lifespan of up to 20 years, or twice the usual PE fund life cycle, according to a news report by the Blomberg citing sources.VC Circle, 2 days ago Carlyle promotes Neeraj Bharadwaj as partner VC Circle, 4 weeks ago
Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies. lvcandy/Gettyimages Distant destinations have never looked better for multinational and middle market life-sciences companies.PharmTech.com, 3 days ago
NEW DELHI: The S&P BSE Sensex cracked over 400 points in the last one hour of trade on Monday weighed down by over 2 per cent cut seen in the European markets. The fall in the domestic market was led by losses in ITC, Infosys, ICICI Bank, and HDFC. ...Economic Times, 4 days ago
SENSEX 24287.42 329.55 1.34% NIFTY 7387.25 101.85 1.36% Indian equity benchmarks added strength to continue its firm trade in the late afternoon session on account of buying in front line blue chip counters. Investors however ...Finalaya.com, 4 days ago
Benchmark indices BSE Sensex and NSE Nifty opened on a flat note on Monday. The BSE Sensex opened 20.44 points up at 24637.41, while NSE Nifty opened 0.60 points up at 7489.70. Below are 12 stock which are likely to remain in focus today. GMR ...Yahoo! India, 4 days ago
on your WebpageAdd Widget >Get your members hooked!